John P. Kenny is CEO at MERIDIAN BIOSCIENCE INC (VIVO). They have made 13 open-market trades across 2 companies since 2019, most recently 2026-09-06.
CIK 0001719325
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $936K since 2019, against 8 sales. Across 5 scored buys the stock is up 44.4% at ninety days, and 39.0 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 40% | 60% |
| Avg Move | +4.4% | +12.1% | +44.4% |
| Alpha | +6.0% | +14.1% | +39.0% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OSUR | BUY | 2025-02-27 | 2025-02-27 | $3.17 | $302K | +0.1% | -0.2% | -18.0% |
| VIVO | SELL | 2022-06-24 | 2022-06-28 | $30.35 | $4.1M | +5.6% | +2.4% | +1.7% |
| VIVO | SELL | 2022-06-22 | 2022-06-24 | $29.80 | $3.9M | +10.2% | +8.0% | +6.0% |
| VIVO | SELL | 2021-03-17 | 2021-03-18 | $25.00 | $750K | +1.9% | -9.6% | -18.1% |
| VIVO | SELL | 2021-03-10 | 2021-03-11 | $25.00 | $250K | +13.2% | +1.6% | -14.0% |
| VIVO | SELL | 2021-02-16 | 2021-02-17 | $30.35 | $143K | -17.6% | -3.8% | -27.1% |
| VIVO | SELL | 2021-02-11 | 2021-02-16 | $30.14 | $1.6M | -20.6% | -6.4% | -27.5% |
| VIVO | SELL | 2021-02-08 | 2021-02-10 | $29.86 | $4.1M | -23.9% | -14.9% | -33.3% |
| VIVO | SELL | 2021-02-05 | 2021-02-08 | $25.00 | $500K | -16.8% | -17.1% | -35.9% |
| VIVO | BUY | 2020-03-12 | 2020-03-13 | $5.78 | $173K | +11.3% | +56.1% | +167.1% |
| VIVO | BUY | 2020-02-21 | 2020-02-24 | $7.65 | $77K | +5.1% | -14.4% | +80.5% |
| VIVO | BUY | 2019-11-08 | 2019-11-12 | $7.73 | $155K | +8.4% | +20.0% | +0.1% |
| VIVO | BUY | 2019-05-08 | 2019-05-09 | $11.49 | $230K | -3.0% | -0.9% | -7.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.